Virtu Financial’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,016
| Closed | -$50K | – | 1632 |
|
|
2024
Q3 | $50K | Buy |
+4,016
| New | +$50K | ﹤0.01% | 1012 |
|
|
2024
Q1 | – | Sell |
-2,059
| Closed | -$39K | – | 1526 |
|
|
2023
Q4 | $39K | Buy |
+2,059
| New | +$39K | ﹤0.01% | 1214 |
|
|
2023
Q3 | – | Sell |
-954
| Closed | -$29K | – | 1414 |
|
|
2023
Q2 | $29K | Buy |
+954
| New | +$29K | ﹤0.01% | 1206 |
|
|
2023
Q1 | – | Sell |
-1,560
| Closed | -$31K | – | 1615 |
|
|
2022
Q4 | $31K | Buy |
+1,560
| New | +$31K | ﹤0.01% | 1173 |
|
|
2022
Q3 | – | Sell |
-3,256
| Closed | -$75K | – | 1810 |
|
|
2022
Q2 | $75K | Buy |
+3,256
| New | +$75K | 0.01% | 1007 |
|
|
2021
Q3 | – | Sell |
-789
| Closed | -$69K | – | 1588 |
|
|
2021
Q2 | $69K | Buy |
+789
| New | +$69K | 0.01% | 1278 |
|
|
2021
Q1 | – | Sell |
-5,907
| Closed | -$151K | – | 1664 |
|
|
2020
Q4 | $151K | Buy |
5,907
+1,338
| +29% | +$34.2K | 0.02% | 944 |
|
|
2020
Q3 | $119K | Buy |
4,569
+897
| +24% | +$23.4K | 0.02% | 691 |
|
|
2020
Q2 | $104K | Buy |
+3,672
| New | +$104K | 0.01% | 871 |
|
|
2019
Q4 | – | Sell |
-661
| Closed | -$13K | – | 1503 |
|
|
2019
Q3 | $13K | Buy |
+661
| New | +$13K | ﹤0.01% | 1327 |
|